Skip to content
10-Q

Quarterly Report

Cascadian Therapeutics, Inc.

0001387131-17-003983

← back to feed
Filed
Aug 8, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2017 · Aug 8, 2017 50.55M sh
Capex Q2 2017 · Jun 30, 2017 $477K
Capex Q2 2017 · Jun 30, 2016 $59K
Short Term Investments Q2 2017 · Jun 30, 2017 $109.81M
Short Term Investments Q2 2017 · Dec 31, 2016 $49.08M
Cash And Equivalents Q2 2017 · Jun 30, 2017 $12.92M
Cash And Equivalents Q2 2017 · Dec 31, 2016 $13.72M
Cash And Equivalents Q2 2017 · Jun 30, 2016 $51M
Cash And Equivalents Q2 2017 · Dec 31, 2015 $27.85M
Stockholders Equity Q2 2017 · Jun 30, 2017 $137.91M
Stockholders Equity Q2 2017 · Dec 31, 2016 $74.36M
Current Liabilities Q2 2017 · Jun 30, 2017 $7.53M
Current Liabilities Q2 2017 · Dec 31, 2016 $8.77M
Current Assets Q2 2017 · Jun 30, 2017 $123.86M
Current Assets Q2 2017 · Dec 31, 2016 $64.45M
Total Assets Q2 2017 · Jun 30, 2017 $145.51M
Total Assets Q2 2017 · Dec 31, 2016 $83.27M
Sga Expense Q2 2017 · Jun 30, 2017 $3.51M
Sga Expense Q2 2017 · Jun 30, 2017 $6.48M
Sga Expense Q2 2017 · Jun 30, 2016 $4.37M
Sga Expense Q2 2017 · Jun 30, 2016 $11M
Rd Expense Q2 2017 · Jun 30, 2017 $11.51M
Rd Expense Q2 2017 · Jun 30, 2017 $20.1M
Rd Expense Q2 2017 · Jun 30, 2016 $6.38M
Rd Expense Q2 2017 · Jun 30, 2016 $12.72M
Net Income Q2 2017 · Jun 30, 2017 −$14.71M
Net Income Q2 2017 · Jun 30, 2017 −$26.11M
Net Income Q2 2017 · Jun 30, 2016 −$23.53M
Net Income Q2 2017 · Jun 30, 2016 −$36.42M
Operating Income Q2 2017 · Jun 30, 2017 −$15.02M
Operating Income Q2 2017 · Jun 30, 2017 −$26.58M
Operating Income Q2 2017 · Jun 30, 2016 −$30.48M
Operating Income Q2 2017 · Jun 30, 2016 −$43.45M